Cell fusion corrects the 4-nitroquinoline 1-oxide sensitivity of Werner syndrome fibroblast cell lines

Hum Genet. 1999 Jul-Aug;105(1-2):132-8. doi: 10.1007/s004399900078.

Abstract

We have shown that Werner syndrome (WRN) fibroblast cell lines are unusually sensitive to the DNA-damaging agent 4-nitroquinoline 1-oxide (4NQO), though not to gamma radiation or to hydrogen peroxide. The fusion of 4NQO-sensitive WRN and 4NQO-resistant control fibroblast cell lines generated proliferating WRN x control cell hybrids that expressed WRN protein and were 4NQO-resistant. These results establish the recessive nature of 4NQO sensitivity in WRN cell lines and provide a cellular assay for WRN protein function.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 4-Nitroquinoline-1-oxide / pharmacology*
  • Alleles
  • Blotting, Western
  • Cell Fusion*
  • Cell Line, Transformed
  • Cell Survival
  • DNA Damage
  • Dose-Response Relationship, Drug
  • Dose-Response Relationship, Radiation
  • Drug Resistance
  • Fibroblasts / drug effects*
  • Genotype
  • Humans
  • Mutagens / pharmacology*
  • Phenotype
  • Transfection
  • Werner Syndrome / genetics*

Substances

  • Mutagens
  • 4-Nitroquinoline-1-oxide